Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

WHiTE 8 COPAL, a randomised controlled trial embedded in the World Hip Trauma Evaluation study, opened to recruitment on Friday, August 17th and recruited its first patient on the same day. WHiTE 8 will be recruiting for 30 months at 24 hospitals across the UK. The study aims to establish whether a high dose dual antibiotic regime has fewer infections compared to low dose single antibiotic cement in the treatment of cemented hemiarthroplasties in patients who have suffered a displaced intracapsular fracture of the neck of femur. For more information about the WHiTE 8 trial, please visit https://white8.octru.ox.ac.uk/

 

Similar stories

Taking a break from immune-suppressing medicines doubles the antibody response to COVID-19 booster vaccination

The Oxford Clinical Trials Research Unit (OCTRU) at NDORMS played a key role in the VROOM study which found that pausing immune-suppressing medicines such as methotrexate can increase the response to COVID-19 booster jabs.

Celebrating Clinical Trials Day at NDORMS

To mark Clinical Trials Day we take a look at some of the recent developments at NDORMS and celebrate the teams that make this important area of our research programme possible.

Breakthrough in treatment for Dupuytren’s disease

Injection of the anti-TNF drug adalimumab into Dupuytren’s disease nodules is effective in reducing nodule hardness and nodule size.

Liposomal bupivacaine found to be no more effective than current treatments for post-operative knee pain

A new study published in JAMA, has found that a drug recently licensed in the UK has no effect on post-operative knee replacement recovery or pain, compared to the current treatment when administered at site of surgery.

Cemented hip replacement improves quality of life for patients over 60

The White 5 trial compared implants fixed with bone cement against uncemented implants for hip fractures treated with hemiarthroplasty.